Product Details

PMS-Fluoxetine

Fluoxetine HCl
40 mg
Capsule


DIN/PIN/NPN

02464640

Manufacturer

Pharmascience Inc.

Formulary Listing Date

2021-02-26  

Unit Price

0.6622

Amount MOH Pays

0.6622

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Fluoxetine HCl: Because of the long half-life of the fluoxetine metabolite, steady-state concentrations occur only after 4-6 weeks. Use with caution in anorexic patients. Fluoxetine therapy should be discontinued for 5 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting fluoxetine.

ATC Code

N06AB03

Interchangeable Products

NO  

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph